FIGS Inc
FIGS
14.06
-0.04
-0.28%
FIGS Inc
US · FIGS
#2710 by market cap
Listed 2021
14.06
-0.04
-0.28%
Live - 5344 symbols - heartbeat 198s ago
· 2026-10-08 08:26
Pre-market
13.81
-1.78%
After-hours
13.95
-0.78%
- Market cap
- 2.34B
- P/E (TTM)i
- 42.61
- P/Bi
- 5.28
- EPSi
- 0.19
- Div yieldi
- 0.00%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on FIGS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 12.11, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +13.60% YoY
Margins
- Gross margin
- 66.53%
- Operating margin
- 6.04%
- Net margin
- 5.43%
Key ratios & quality
- PEG ratioi
- 2.45
- Altman Z-Scorei
- 12.11
PEG uses trailing P/E against the 3-year net income growth rate (17.36%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 110.49M | 263.11M | 419.59M | 505.84M | 545.65M | 555.56M | 631.10M |
| Gross profit | 79.34M | 190.22M | 301.22M | 354.46M | 376.96M | 375.62M | 419.84M |
| Selling & admin expenses | 79.68M | 132.28M | 290.24M | 316.79M | 342.92M | 373.36M | 381.69M |
| Research & development | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -347.00K | 57.94M | 10.98M | 37.67M | 34.05M | 2.27M | 38.15M |
| Pretax profit | 112.00K | 58.08M | 9.86M | 38.73M | 40.81M | 14.34M | 47.21M |
| Tax | 0 | 8.32M | 19.42M | 17.54M | 18.17M | 11.62M | 12.96M |
| Net profit | 112.00K | 49.76M | -9.56M | 21.19M | 22.64M | 2.72M | 34.25M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.00 | 0.31 | -0.06 | 0.11 | 0.12 | 0.02 | 0.19 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 124.90M | 152.64M | 151.66M | 201.90M | 159.90M | 196.62M |
| Gross profit | 84.46M | 102.25M | 106.07M | 127.07M | 108.30M | 147.86M |
| Selling & admin expenses | 84.67M | 92.33M | 96.43M | 108.26M | 103.82M | 112.59M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -211.00K | 9.92M | 9.64M | 18.81M | 4.48M | 35.26M |
| Pretax profit | 1.86M | 12.03M | 11.96M | 21.35M | 6.45M | 36.88M |
| Tax | 1.97M | 4.93M | 3.21M | 2.85M | 157.00K | 8.50M |
| Net profit | -102.00K | 7.10M | 8.75M | 18.51M | 6.29M | 28.38M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.00 | 0.04 | 0.05 | 0.10 | 0.03 | 0.15 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 56.40M | 120.31M | 293.34M | 356.50M | 385.66M | 382.77M | 447.29M |
| Cash & ST investments | 38.35M | 58.13M | 195.37M | 159.78M | 246.70M | 245.11M | 300.85M |
| Inventory | 14.30M | 49.74M | 86.07M | 177.98M | 119.04M | 115.76M | 127.97M |
| Total assets | 62.60M | 133.86M | 311.75M | 395.06M | 473.21M | 509.79M | 580.00M |
| Total current liabilities | 20.86M | 32.52M | 62.39M | 71.39M | 57.29M | 90.14M | 90.52M |
| Short-term debt | -- | -- | -- | 3.41M | 8.23M | 10.60M | 8.18M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 23,784,000.00 | 36,178,000.00 | 66,178,000.00 | 87,325,000.00 | 96,359,000.00 | 132,655,000.00 | 142,534,000.00 |
| Total equity | 38.81M | 97.68M | 245.57M | 307.74M | 376.85M | 377.13M | 437.46M |
| Retained earnings | -22.27M | 27.49M | 17.93M | 39.12M | 61.75M | 64.47M | 98.72M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 399.71M | 393.61M | 418.02M | 447.29M | 432.19M | 452.93M |
| Cash & ST investments | 251.21M | 238.84M | 241.53M | 300.85M | 277.03M | 296.29M |
| Inventory | 131.58M | 135.53M | 151.23M | 127.97M | 139.38M | 119.56M |
| Total assets | 522.31M | 517.12M | 544.74M | 580.00M | 563.44M | 582.68M |
| Total current liabilities | 100.97M | 78.36M | 86.66M | 90.52M | 80.20M | 91.38M |
| Short-term debt | 11.60M | 9.55M | 9.45M | 8.18M | 8.27M | 9.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 140,778,000.00 | 120,593,000.00 | 131,409,000.00 | 142,534,000.00 | 132,802,000.00 | 140,312,000.00 |
| Total equity | 381.54M | 396.53M | 413.33M | 437.46M | 430.64M | 442.37M |
| Retained earnings | 64.37M | 71.47M | 80.22M | 98.72M | 105.01M | 133.39M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.53M | 21.75M | 66.44M | -35.33M | 100.92M | 81.16M | 61.17M |
| Depreciation & amortization | 517.00K | 946.00K | 1.42M | 1.92M | 2.94M | 6.69M | 9.04M |
| Free cash flow | 1.77M | 19.49M | 63.73M | -40.68M | 84.57M | 64.14M | 53.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 97.18M | 479.00K | 0 | -45.20M | -2.69M |
| Ending cash balance | 38.35M | 58.13M | 197.43M | 159.78M | 144.17M | 85.65M | 81.99M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.24M | -12.43M | 3.44M | 60.93M | -3.20M | 46.86M |
| Depreciation & amortization | 2.00M | 2.15M | 2.33M | 2.56M | 3.41M | 2.37M |
| Free cash flow | 7.93M | -13.52M | 531.00K | 58.07M | -5.63M | 44.26M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -2.69M | 0 | 0 | 0 | -8.80M | -24.02M |
| Ending cash balance | 90.01M | 50.85M | 46.45M | 81.99M | 74.30M | 108.54M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | 0.29 | 72.91 | -5.57 | 7.66 | 6.61 | 0.72 | 8.41 |
| ROA %i | 0.18 | 50.66 | -4.29 | 5.99 | 5.21 | 0.55 | 6.29 |
| ROIC %i | -0.90 | 72.74 | -5.47 | 6.71 | 4.60 | -1.44 | 6.02 |
| 5-year avg ROE %i | -- | -- | -- | -- | 16.38 | 16.47 | 3.57 |
| EBIT margin %i | -0.31 | 22.02 | 2.41 | 7.45 | 6.24 | 0.41 | 6.04 |
| FCF / sales %i | 1.60 | 7.41 | 15.19 | -- | 15.50 | 11.55 | 8.40 |
| Current ratioi | 2.70 | 3.70 | 4.70 | 4.99 | 6.73 | 4.25 | 4.94 |
| Quick ratioi | 1.92 | 1.97 | 3.17 | 2.33 | 4.44 | 2.81 | 3.39 |
| Debt / assetsi | -- | -- | 0.00 | 4.85 | 9.96 | 10.40 | 10.35 |
| LT debt / equityi | -- | -- | -- | 5.12 | 10.32 | 11.25 | 11.85 |
| Interest coveragei | -- | -- | 42.25 | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 66.04 | 27.52 | 9.81 | 7.65 |
| Net income CAGR (3Y) %i | -- | -- | -- | 474.04 | -23.09 | -- | 17.36 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 63.11 | 0.22 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 0.31 | 1.80 | 4.32 | 8.41 | 10.01 | 14.76 |
| ROA %i | 0.23 | 1.38 | 3.24 | 6.29 | 7.49 | 11.26 |
| ROIC %i | -1.61 | -0.12 | 2.24 | 6.02 | 7.28 | 11.54 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.29 | 1.75 | 4.86 | 6.04 | 6.43 | 9.60 |
| FCF / sales %i | 10.86 | 7.00 | 3.78 | 8.40 | 5.92 | 13.69 |
| Current ratioi | 3.96 | 5.02 | 4.82 | 4.94 | 5.39 | 4.96 |
| Quick ratioi | 2.55 | 3.16 | 2.93 | 3.39 | 3.52 | 3.50 |
| Debt / assetsi | 9.83 | 10.00 | 9.93 | 10.35 | 10.76 | 9.90 |
| LT debt / equityi | 10.41 | 10.63 | 10.81 | 11.85 | 12.15 | 11.00 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Scrubwear is the largest reported line at 82.00% of revenue, across 2 reported segments.
- The next-largest line, Non-Scrubwear, is a distant second at 18.00% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Scrubwear82.00%
Non-Scrubwear18.00%
Quote time 2026-10-08 08:26:35 · For reference only, not investment advice and not tailored to your situation.